Drug profile · INN
clevidipine
CLEVIPREX
clevidipine (CLEVIPREX) is a voltage-gated l-type calcium channel blocker. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — clevidipine
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
clevidipine (CLEVIPREX) is a voltage-gated l-type calcium channel blocker. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is clevidipine?
clevidipine (CLEVIPREX) is a voltage-gated l-type calcium channel blocker. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for clevidipine?
CLEVIPREX is a marketed brand name for clevidipine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clevidipine?
clevidipine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.